Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Representation of women in randomized clinical trials of cardiovascular disease prevention.

Melloni C, Berger JS, Wang TY, Gunes F, Stebbins A, Pieper KS, Dolor RJ, Douglas PS, Mark DB, Newby LK.

Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):135-42. doi: 10.1161/CIRCOUTCOMES.110.868307. Epub 2010 Feb 16. Review.

2.
3.

The female heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women.

Wenger NK.

Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):118-9. doi: 10.1161/CIRCOUTCOMES.110.942664. No abstract available.

4.

What can we learn from design faults in the Women's Health Initiative randomized clinical trial?

Tan O, Harman SM, Naftolin F.

Bull NYU Hosp Jt Dis. 2009;67(2):226-9.

5.

[Controlled randomized clinical trials].

Jaillon P.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):739-56; discussion 756-8. French.

PMID:
18225427
6.

Heart association issues new guidelines on cardiovascular disease prevention in women.

Rollins G.

Rep Med Guidel Outcomes Res. 2004 Feb 20;15(4):1-2, 6-7. No abstract available.

PMID:
15000094
7.

Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine.

Anastos K, Charney P, Charon RA, Cohen E, Jones CY, Marte C, Swiderski DM, Wheat ME, Williams S.

Ann Intern Med. 1991 Aug 15;115(4):287-93. Review.

PMID:
1854113
8.
9.

State of the heart: building science to improve women's cardiovascular health.

Rosenfeld AG.

Am J Crit Care. 2006 Nov;15(6):556-66; quiz 567. Review.

10.
12.

Reporting and representation of race/ethnicity in published randomized trials.

Berger JS, Melloni C, Wang TY, Dolor RJ, Frazier CG, Samad Z, Peterson ED, Mark DB, Newby LK.

Am Heart J. 2009 Nov;158(5):742-7. doi: 10.1016/j.ahj.2009.08.018. Epub 2009 Sep 29.

PMID:
19853691
13.

The impact of cardiovascular disease prevalence on women's enrollment in landmark randomized cardiovascular trials: a systematic review.

Tsang W, Alter DA, Wijeysundera HC, Zhang T, Ko DT.

J Gen Intern Med. 2012 Jan;27(1):93-8. doi: 10.1007/s11606-011-1768-8. Epub 2011 Jun 29. Review.

14.
15.

Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials.

Ding EL, Powe NR, Manson JE, Sherber NS, Braunstein JB.

Arch Intern Med. 2007 May 14;167(9):905-12.

PMID:
17502531
16.
17.

Cardiovascular disease prevention tailored for women.

Engberding N, Wenger NK.

Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1123-34. doi: 10.1586/14779072.6.8.1123. Review.

PMID:
18793115
18.
19.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
20.

Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.

Abramson BL.

J Cardiovasc Risk. 2002 Dec;9(6):309-14. Review.

PMID:
12478199

Supplemental Content

Support Center